FDA product code OCL: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue

OCL is the FDA product code for surgical device, for cutting, coagulation, and/or ablation of tissue, including cardiac tissue. It is a Class II device, regulated under 21 CFR 878.4400 and reviewed by the Cardiovascular panel. FDA has cleared 54 510(k) submissions under OCL, 4 in the last five years, from 14 different applicants. The average 510(k) review took 105 days (median 80); 132 days on average over the last three years. FDA has posted 17 recalls for OCL devices, 1 initiated in the last five years.

Definition

Surgical device for cutting, coagulation, and/or ablation of tissue, including cardiac tissue

Classification

FieldValue
Device nameSurgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
Device classClass II
Regulation21 CFR 878.4400
Review panelCV — Cardiovascular
Medical specialtyGeneral, Plastic Surgery
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for OCL

YearClearancesAvg. review days
2017129
2018259
2019679
2020193
2021292
20222132
20241242
2025123

Compare with all 510(k) review times · Search every OCL clearance

Top OCL applicants

ApplicantClearancesLatest
AtriCure, Inc.202025-07-24
Medtronic, Inc.72022-12-22
Ncontact Surgical, Inc.62014-10-28
Medtronic42020-06-03
Cryocath Technologies, Inc.32006-08-24

9 more applicants have OCL clearances. See the full list in Caduvo.

Most recent OCL clearances

510(k)ApplicantDeviceDecision dateReview days
K252056AtriCure, Inc.Isolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)2025-07-2423
K234151AtriCure, Inc.Isolator Synergy EnCapture Ablation System (EMH)2024-08-27242
K221358AtriCure, Inc.Isolator® Linear Pen (MLP1); Isolator® Transpolar™ Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy™ EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1)2022-12-30233
K223508Medtronic, Inc.Cardioblate Gemini-s 49260 Surgical Ablation Device; Cardioblate Gemini-s 49351 Surgical Ablation Device2022-12-2230
K210477AtriCure, Inc.AtriCure Isolator Encompass Ablation System, GLIDEPATH Magnetic GUIDE2021-07-26157

Recalls for OCL devices

17 product recalls in 10 recall events; 1 initiated in the last five years and 2 still open. Most recent: 2022-04-20.

YearRecalls
20195
20204
20211
20221

Frequently asked questions

What is FDA product code OCL?

OCL is the FDA product code for surgical device, for cutting, coagulation, and/or ablation of tissue, including cardiac tissue. It is a Class II device, regulated under 21 CFR 878.4400 and reviewed by the Cardiovascular panel.

What device class is OCL?

Class II, regulation 21 CFR 878.4400. Typical premarket route: 510(k).

How long does a 510(k) take for product code OCL?

Across 54 cleared submissions the average was 105 days from receipt to decision (median 80).

Which companies have the most OCL clearances?

AtriCure, Inc. (20); Medtronic, Inc. (7); Ncontact Surgical, Inc. (6); Medtronic (4); Cryocath Technologies, Inc. (3).

Have OCL devices been recalled?

Yes: 17 product recalls across 10 recall events; the most recent began 2022-04-20.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times